BAYER vs LCLA: Side-by-Side Comparison
Compare Bayer AG (BAYER) and PT Kalbe Farma Tbk (LCLA) side by side: market cap HUF 16.70T vs EUR 2.13B. Financials, growth and model signals on Bullrun.
| Metric | BAYER | LCLA |
|---|---|---|
| Company | Bayer AG | PT Kalbe Farma Tbk |
| Country / Exchange | Germany · BUD | Indonesia · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | HUF 16.70T | EUR 2.13B |
| P/E ratio | — | — |
| Dividend yield | 0.24% | 2.93% |
| Valuation model | — | — |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |